Q2: Sales of EUR 45m (36m), adj. EBIT of -EUR 1.1m (-0.
* Another strong quarter for P&M orders * Sales EUR 44.
* Q2: Sales of EUR ~37m (~36m), adj. EBIT of 3.5m (-0.
* Q1: Sales of EUR 33m (39m), EBIT of EUR -2.8m (0.
* Sales EUR 60m vs ABGSCe, EBIT adj. EUR -2.8m vs. ABGSCe 2.
* Q1: Sales of EUR 44m (39m), EBIT of EUR 2.5m (0.8m) * 4% '26e EBIT raised following continued strength in Industry * Trading at 16-9x EV/E...
* Solid Q4 but continued cautious order environment * Industry bright spot, initiatives delivering * Customer caution in P&M, expected to so...
* Sales +34% vs EBIT adj. EUR 3.9m vs. ABGSCe 0.7m * Orders in line vs.
* Q4e: Sales of EUR 37m (45m), EBIT of EUR 0.7m (3.
* Customer caution weighing on estimates * We lower '25e-'27e sales by 11-4% and adj.
* Sales in line, EBIT adj. EUR +0.5m vs. ABGSCe * Orders -18% vs.
* Report out on 7 November * Q3e sales of EUR 40m (44m), EBIT EUR 2.
Lower sales but demand for shore power solid Cavotec reported sales of EUR 36m (17% below our estimate) and order intake of EUR 44m (7% abov...
Stronger order intake, but lower sales Cavotec reported order intake of EUR 44m (+7% vs.
Q2 expectations We expect Q2 sales of EUR 43m, +1% y-o-y and +11% q-o-q.
Q1 disappointed, but likely better from here Orders -33%, sales -13%, EBIT adj.
Weak Q1 but management remain positive on demand Orders -33%, sales -13% vs.
Report out 25 April at 07.00 CEST Q1e sales of EUR 45m +4% y-o-y, EBIT EUR 3.
Solid Q4, despite tough comps Strong orders (+52% y-o-y) and profitability improvements 14x-9x '25e-'27e EV/EBIT Orders picking up Despite ...
Orders +43%, sales -3% vs. ABGSCe EBIT adj. EUR 3.8m, for a margin of 8.
Q4 report due on 21 February Q4e sales: EUR 47m, order intake: EUR 43m Several orders announced during the quarter Q4 expectations We expec...
Q3 sales EUR 44m (+5% y-o-y), order intake EUR 36m (-5% y-o-y) Margin improvements but slight decline in orders We raise '24e-'26e sales +2%...
Orders -9%, sales +10% vs. ABGSCe EBIT EUR 3m (vs. ABGSCe 2m), for a margin of 7% Profitability improvements driven by P&M division Q3: Pro...
- Q3 report out on 8 November, 07:00 CET - '24e-'26 sales and EBIT ests.
- Q2 sales EUR 43m, -7% y-o-y, order intake EUR 40m, +11% y-o-y - Minor adjustments to '24-'26 estimates - FCF positive, continued focus on ...
- Orders -6% vs ABGSCe, sales in line, EBIT 31% above - Adj.
Q2e: Positive margin trends and cash flow We expect Q2 sales of EUR 42.
Q1: sales EUR 42m, +9% y-o-y, order intake EUR 40m, -5% y-o-y We lower '24e-'26e sales and order intake by 6-10% and 4-6% Keep margin estima...
Sales -3%, EBIT +15%, order book -2% v.s. ABGSCe EBIT margin strengthened to 4.
Q1 report due Wednesday 15 May at 07:00 CEST Q1e: sales EUR 44.
Positive margin, sales and cash flow trend continues '24e-'25e EBIT up 11-4%; 53% CAGR '23-'26e 12-5x EBIT '24e-'26e, 3-10% FCF yields Four...
Sales +17% org., EBIT margin 7.6% (ABGSCe 5.6%), good FCF Encouraging momentum, Q4 beat in isolation lifts '24 EBIT by ~10% Better growth, p...
Q4 report due Friday, 23 February at 07:00 CET 6.0-9.
Better margins and FCF, lower sales and orders '23e/'24e/'25e EBIT down 4/6/2%; 4.
1% org. sales (ABGSCe 19%), 4.1% margin (ABGSCe 3.8%) Q3 in isolation would yield limited estimate revisions Small positive due to margins, ...
• Good sales and margins, lower orders and FCF • EBIT estimates largely unchanged '23e-'25e • 19-7x EBIT '23e-'24e, 17% org.
• 45% organic sales, 2.6% EBIT margin (ABGSCe 1.9%) • Guides for gradually improving margins in 2023 • Some positives and negatives, likely ...
Orders remain strong while EBIT turns positive 4.2-9.
45% organic sales, 1% EBIT margin (ABGSCe neg.) Guides for a "steady improvement" in margins for 2023 A positive start to the year Q1 detai...
Q1 report Thursday, 27 April, 07:00 CET '23e EBIT -2%, '24e EBIT up 1% 26-7x EBIT '23e-'24e, 18% org.
Cost headwinds persist, share issue strengthens cash position 3.
12% (pre-Q4) dilutive EPS impact, ND from EUR 30m to 15m Alleviates gearing concerns until earnings improve Positive, but need to show impro...
Higher sales, but also higher losses Solid demand outlook, some caution on margins Margins and neg.
Q4 report due Wednesday, 22 February, 07:00 CET '23e-'24e EBIT down 4-3%, mainly due to FX 12-5x EBIT '23e-'24e, gradual ramp-up in margins ...
Strong backlog, growth in sales and break-even EBIT ‘22e EBIT up 2%, ‘23e-‘24e EBIT down 9-4% ‘24e EBIT 4x above ‘22e, 24% org.
Backlog +98% y-o-y, sales +20% organically, break-even Airports exit to be finalised this week, ramp-up in H2’22 Positive quarterly performa...
10% of our 2022e order backlog, Q1’22 BTB was 1.5x Deliveries from the backlog key to profitability ‘24e EBIT 4x above ‘22e, 26% org.
Annualised orders approaching ~EUR 200m Return to profitability in H2’22e ’24e EBIT 4x above ’22e, 26% org.
Continued strong backlog build-up, bank amendment China production expected to resume mid-May Small positive relief expected Q1 details Con...
David Pagels, CEO at Dellner Couplers 2013-2021 Track record of driving profitable growth in industrials A good candidate at first glance D...
Q2 results Market activity is improving, especially in ports.
